Optimizing Treatment with TNF Inhibitors in Inflammatory Bowel Disease by Monitoring Drug Levels and Antidrug Antibodies
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Optimizing Treatment with TNF Inhibitors in Inflammatory Bowel Disease by Monitoring Drug Levels and Antidrug Antibodies
Authors
Keywords
-
Journal
INFLAMMATORY BOWEL DISEASES
Volume 22, Issue 8, Pages 1999-2015
Publisher
Oxford University Press (OUP)
Online
2016-04-30
DOI
10.1097/mib.0000000000000772
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systematic review with meta-analysis: infliximab and immunosuppressant therapy vs. infliximab alone for active ulcerative colitis
- (2015) D. Christophorou et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Population pharmacokinetics of infliximab in patients with inflammatory bowel disease: potential implications for dosing in clinical practice
- (2015) D. J. Buurman et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Systematic review: factors associated with relapse of inflammatory bowel disease after discontinuation of anti-TNF therapy
- (2015) J. P. Gisbert et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Undetectable anti-TNF drug levels in patients with long-term remission predict successful drug withdrawal
- (2015) S. Ben-Horin et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Systematic review with meta-analysis: the efficacy of a second anti-TNF in patients with inflammatory bowel disease whose previous anti-TNF treatment has failed
- (2015) J. P. Gisbert et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Review article: applying pharmacokinetics to optimise dosing of anti-TNF biologics in acute severe ulcerative colitis
- (2015) M. J. Rosen et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Transient and Persistent Antibodies Against TNF-Inhibitors in IBD
- (2015) Casper Steenholdt AMERICAN JOURNAL OF GASTROENTEROLOGY
- The Impact of Preoperative Serum Anti-TNFα Therapy Levels on Early Postoperative Outcomes in Inflammatory Bowel Disease Surgery
- (2015) Cheryl Lau et al. ANNALS OF SURGERY
- Long-Term Outcome of Patients With Crohn’s Disease Who Discontinued Infliximab Therapy Upon Clinical Remission
- (2015) Konstantinos Papamichael et al. Clinical Gastroenterology and Hepatology
- A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis
- (2015) Maria Theresa Arias et al. Clinical Gastroenterology and Hepatology
- Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti–Tumor Necrosis Factor Therapy for Crohn’s Disease: A Meta-analysis of Placebo-controlled Trials
- (2015) Jennifer L. Jones et al. Clinical Gastroenterology and Hepatology
- Concentrations of 6-Thioguanine Nucleotide Correlate With Trough Levels of Infliximab in Patients With Inflammatory Bowel Disease on Combination Therapy
- (2015) Andres J. Yarur et al. Clinical Gastroenterology and Hepatology
- Levels of Drug and Antidrug Antibodies Are Associated With Outcome of Interventions After Loss of Response to Infliximab or Adalimumab
- (2015) Henit Yanai et al. Clinical Gastroenterology and Hepatology
- An Accelerated Infliximab Induction Regimen Reduces the Need for Early Colectomy in Patients With Acute Severe Ulcerative Colitis
- (2015) David J. Gibson et al. Clinical Gastroenterology and Hepatology
- Withdrawal of Immunomodulators After Co-treatment Does Not Reduce Trough Level of Infliximab in Patients With Crohn’s Disease
- (2015) David Drobne et al. Clinical Gastroenterology and Hepatology
- Individualized Therapy Is a Long-Term Cost-Effective Method Compared to Dose Intensification in Crohn’s Disease Patients Failing Infliximab
- (2015) Casper Steenholdt et al. DIGESTIVE DISEASES AND SCIENCES
- Infliximab Dose Escalation as an Effective Strategy for Managing Secondary Loss of Response in Ulcerative Colitis
- (2015) Carlos Taxonera et al. DIGESTIVE DISEASES AND SCIENCES
- Comparative Effectiveness of Immunosuppressants and Biologics for Inducing and Maintaining Remission in Crohn's Disease: A Network Meta-analysis
- (2015) Glen S. Hazlewood et al. GASTROENTEROLOGY
- Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease
- (2015) Niels Vande Casteele et al. GASTROENTEROLOGY
- Loss of Infliximab Into Feces Is Associated With Lack of Response to Therapy in Patients With Severe Ulcerative Colitis
- (2015) Johannan F. Brandse et al. GASTROENTEROLOGY
- Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease
- (2015) Joana Torres et al. GASTROENTEROLOGY
- Authors’ response: Importance of defining loss of response before therapeutic drug monitoring
- (2015) C Steenholdt et al. GUT
- Immunogenicity to infliximab is associated with HLA-DRB1
- (2015) Thomas Billiet et al. GUT
- The association of tissue anti-TNF drug levels with serological and endoscopic disease activity in inflammatory bowel disease: the ATLAS study
- (2015) Andres J Yarur et al. GUT
- New Insights into the Mechanisms of Action of Anti–Tumor Necrosis Factor-α Monoclonal Antibodies in Inflammatory Bowel Disease
- (2015) Stephanie M. Slevin et al. INFLAMMATORY BOWEL DISEASES
- Therapeutic Drug Monitoring of Anti-tumor Necrosis Factor Agents in Patients with Inflammatory Bowel Diseases
- (2015) Andres J. Yarur et al. INFLAMMATORY BOWEL DISEASES
- Immune-mediated Reactions to Anti-tumor Necrosis Factors in Inflammatory Bowel Disease
- (2015) Joseph D. Feuerstein et al. INFLAMMATORY BOWEL DISEASES
- Cytokines, IBD, and Colitis-associated Cancer
- (2015) Ralph Francescone et al. INFLAMMATORY BOWEL DISEASES
- Role for Therapeutic Drug Monitoring During Induction Therapy with TNF Antagonists in IBD
- (2015) Konstantinos Papamichael et al. INFLAMMATORY BOWEL DISEASES
- Pharmacokinetics of anti-TNF monoclonal antibodies in inflammatory bowel disease: Adding value to current practice
- (2015) Niels Vande Casteele et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Dashboard systems: Pharmacokinetic/pharmacodynamic mediated dose optimization for monoclonal antibodies
- (2015) Diane R. Mould et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Implications of Infliximab Treatment Failure and Influence of Personalized Treatment on Patient-reported Health-related Quality of Life and Productivity Outcomes in Crohn’s Disease
- (2015) Casper Steenholdt et al. Journal of Crohns & Colitis
- Changes in Serum Trough Levels of Infliximab During Treatment Intensification but not in Anti-infliximab Antibody Detection are Associated with Clinical Outcomes after Therapeutic Failure in Crohn's Disease
- (2015) C. Steenholdt et al. Journal of Crohns & Colitis
- Introducing Vedolizumab to Clinical Practice: Who, When, and How?
- (2015) RV Bryant et al. Journal of Crohns & Colitis
- Ashkenazi Jewish Origin Protects Against Formation of Antibodies to Infliximab and Therapy Failure
- (2015) Bella Ungar et al. MEDICINE
- Global mucosal and serum cytokine profile in patients with ulcerative colitis undergoing anti-TNF therapy
- (2015) Rahil Dahlén et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Withdrawal of anti-tumour necrosis factor α therapy in inflammatory bowel disease
- (2015) Konstantinos Papamichael WORLD JOURNAL OF GASTROENTEROLOGY
- A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's disease
- (2014) B. G. Levesque et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Systematic review with network meta-analysis: the efficacy of anti-TNF agents for the treatment of Crohn's disease
- (2014) R. W. Stidham et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Adalimumab dose escalation is effective for managing secondary loss of response in Crohn's disease
- (2014) C. Ma et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Adalimumab drug and antibody levels as predictors of clinical and laboratory response in patients with Crohn's disease
- (2014) Y. Mazor et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Adalimumab in Crohn's disease patients: pharmacokinetics in the first 6 months of treatment
- (2014) M. R. K. L. Lie et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Systematic review with network meta-analysis: the efficacy of anti-tumour necrosis factor-alpha agents for the treatment of ulcerative colitis
- (2014) R. W. Stidham et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Clinical Implications of Measuring Drug and Anti-Drug Antibodies by Different Assays When Optimizing Infliximab Treatment Failure in Crohn's Disease: Post Hoc Analysis of a Randomized Controlled Trial
- (2014) Casper Steenholdt et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Is it Possible to Change Phenotype Progression in Crohn's Disease in the Era of Immunomodulators? Predictive Factors of Phenotype Progression
- (2014) Fernando Magro et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Development of an Algorithm Incorporating Pharmacokinetics of Adalimumab in Inflammatory Bowel Diseases
- (2014) Xavier Roblin et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Toward a Personalized Medicine Approach to the Management of Inflammatory Bowel Disease
- (2014) Mahmoud H Mosli et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Biological Agents for Moderately to Severely Active Ulcerative Colitis
- (2014) Silvio Danese et al. ANNALS OF INTERNAL MEDICINE
- Early Trough Levels and Antibodies to Infliximab Predict Safety and Success of Reinitiation of Infliximab Therapy
- (2014) Filip Baert et al. Clinical Gastroenterology and Hepatology
- Assessment of the Influence of Inflammation and FCGR3A Genotype on Infliximab Pharmacokinetics and Time to Relapse in Patients with Crohn’s Disease
- (2014) David Ternant et al. CLINICAL PHARMACOKINETICS
- Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed
- (2014) Bruce E. Sands et al. GASTROENTEROLOGY
- Association Between Serum Concentration of Infliximab and Efficacy in Adult Patients With Ulcerative Colitis
- (2014) Omoniyi J. Adedokun et al. GASTROENTEROLOGY
- Postinduction serum infliximab trough level and decrease of C-reactive protein level are associated with durable sustained response to infliximab: a retrospective analysis of the ACCENT I trial
- (2014) Freddy Cornillie et al. GUT
- The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease
- (2014) Niels Vande Casteele et al. GUT
- Identification of inflammatory mediators in patients with Crohn's disease unresponsive to anti-TNFα therapy
- (2014) Raquel Franco Leal et al. GUT
- Stopping Anti-TNF Agents in Patients with Crohnʼs Disease in Remission
- (2014) Dario Sorrentino et al. INFLAMMATORY BOWEL DISEASES
- Patient Factors That Increase Infliximab Clearance and Shorten Half-life in Inflammatory Bowel Disease
- (2014) Iris Dotan et al. INFLAMMATORY BOWEL DISEASES
- Implementable Strategies and Exploratory Considerations to Reduce Costs Associated with Anti-TNF Therapy in Inflammatory Bowel Disease
- (2014) K. T. Park et al. INFLAMMATORY BOWEL DISEASES
- Tumor Necrosis Factor-Alpha Antagonists Twenty Years Later
- (2014) Anthony A. Akobeng et al. INFLAMMATORY BOWEL DISEASES
- Long-term Combination Therapy with Infliximab Plus Azathioprine Predicts Sustained Steroid-free Clinical Benefit in Steroid-dependent Ulcerative Colitis
- (2014) Alessandro Armuzzi et al. INFLAMMATORY BOWEL DISEASES
- Pharmacokinetics of Adalimumab in Inflammatory Bowel Diseases
- (2014) Stephane Paul et al. INFLAMMATORY BOWEL DISEASES
- Antibodies Against Infliximab Are Associated with De Novo Development of Antibodies to Adalimumab and Therapeutic Failure in Infliximab-to-Adalimumab Switchers with IBD
- (2014) Madeline Therese Frederiksen et al. INFLAMMATORY BOWEL DISEASES
- Proactive Therapeutic Concentration Monitoring of Infliximab May Improve Outcomes for Patients with Inflammatory Bowel Disease
- (2014) Byron P. Vaughn et al. INFLAMMATORY BOWEL DISEASES
- Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy
- (2014) K. Subramaniam et al. INTERNAL MEDICINE JOURNAL
- In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease
- (2014) Raja Atreya et al. NATURE MEDICINE
- Tailoring anti-TNF therapy in IBD: drug levels and disease activity
- (2014) Shomron Ben-Horin et al. Nature Reviews Gastroenterology & Hepatology
- Mechanisms of initiation and progression of intestinal fibrosis in IBD
- (2014) Giovanni Latella et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Development of a Universal Anti-Adalimumab Antibody Standard for Interlaboratory Harmonization
- (2014) Ann Gils et al. THERAPEUTIC DRUG MONITORING
- Discontinuation of infliximab therapy in patients with Crohn's disease in sustained complete remission (the STOP IT study): protocol for a double-blind, randomised, placebo-controlled, multicentre trial
- (2014) Sine Schnoor Buhl et al. BMJ Open
- Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel disease
- (2013) R. Khanna et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Pre-existing IgG antibodies cross-reacting with the Fab region of infliximab predict efficacy and safety of infliximab therapy in inflammatory bowel disease
- (2013) C. Steenholdt et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Antibody Response to Infliximab and its Impact on Pharmacokinetics can be Transient
- (2013) Niels Vande Casteele et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- A Test-based Strategy Is More Cost Effective Than Empiric Dose Escalation for Patients With Crohn's Disease Who Lose Responsiveness to Infliximab
- (2013) Fernando S. Velayos et al. Clinical Gastroenterology and Hepatology
- Association Between Pharmacokinetics of Adalimumab and Mucosal Healing in Patients With Inflammatory Bowel Diseases
- (2013) Xavier Roblin et al. Clinical Gastroenterology and Hepatology
- Adalimumab for Crohn’s disease after infliximab treatment failure
- (2013) Wei Da et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Does weight-adjusted anti-tumour necrosis factor treatment favour obese patients with Crohn’s disease?
- (2013) Mahesh Bhalme et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- American Gastroenterological Association Institute Guideline on the Use of Thiopurines, Methotrexate, and Anti–TNF-α Biologic Drugs for the Induction and Maintenance of Remission in Inflammatory Crohn's Disease
- (2013) Jonathan P. Terdiman et al. GASTROENTEROLOGY
- Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2013) William J. Sandborn et al. GASTROENTEROLOGY
- Methotrexate in Combination With Infliximab Is No More Effective Than Infliximab Alone in Patients With Crohn's Disease
- (2013) Brian G. Feagan et al. GASTROENTEROLOGY
- Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis
- (2013) Remo Panaccione et al. GASTROENTEROLOGY
- Individualised therapy is more cost-effective than dose intensification in patients with Crohn’s disease who lose response to anti-TNF treatment: a randomised, controlled trial
- (2013) Casper Steenholdt et al. GUT
- The temporal evolution of antidrug antibodies in patients with inflammatory bowel disease treated with infliximab
- (2013) Bella Ungar et al. GUT
- Increased Body Mass Index Is Associated with Earlier Time to Loss of Response to Infliximab in Patients with Inflammatory Bowel Disease
- (2013) Jason W. Harper et al. INFLAMMATORY BOWEL DISEASES
- Serum Adalimumab Concentration and Clinical Remission in Patients with Crohnʼs Disease
- (2013) Yi-Lin Chiu et al. INFLAMMATORY BOWEL DISEASES
- Antibodies to Infliximab and Risk of Infusion Reactions in Patients With Inflammatory Bowel Disease
- (2013) Sorcha O’Meara et al. INFLAMMATORY BOWEL DISEASES
- High C-reactive protein in Crohn's disease patients predicts nonresponse to infliximab treatment
- (2013) Fernando Magro et al. Journal of Crohns & Colitis
- Clinical utility of newly developed immunoassays for serum concentrations of adalimumab and anti-adalimumab antibodies in patients with Crohn’s disease
- (2013) Hirotsugu Imaeda et al. JOURNAL OF GASTROENTEROLOGY
- C-reactive protein is an indicator of serum infliximab level in predicting loss of response in patients with Crohn’s disease
- (2013) Toshifumi Hibi et al. JOURNAL OF GASTROENTEROLOGY
- Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis
- (2013) Pauline A. van Schouwenburg et al. Nature Reviews Rheumatology
- Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2013) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor Necrosis Factor Inhibitors for Inflammatory Bowel Disease
- (2013) Ole Haagen Nielsen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
- (2013) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of Techniques for Monitoring Infliximab and Antibodies Against Infliximab in Crohnʼs Disease
- (2013) Casper Steenholdt et al. THERAPEUTIC DRUG MONITORING
- Letter: persistence of anti-infliximab antibodies after discontinuation of infliximab in patients with IBD
- (2012) C. Steenholdt et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Outcomes after escalation of infliximab therapy in ambulatory patients with moderately active ulcerative colitis
- (2012) E. Rostholder et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The decline of anti-drug antibody titres after discontinuation of anti-TNFs: implications for predicting re-induction outcome in IBD
- (2012) S. Ben-Horin et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- C-reactive protein, an indicator for maintained response or remission to infliximab in patients with Crohn's disease: a post-hoc analysis from ACCENT I
- (2012) W. Reinisch et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Detection of infliximab levels and anti-infliximab antibodies: a comparison of three different assays
- (2012) N. Vande Casteele et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Genetic polymorphisms of tumour necrosis factor receptor superfamily 1b and fas ligand are associated with clinical efficacy and/or acute severe infusion reactions to infliximab in Crohn's disease
- (2012) C. Steenholdt et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Impact of Antibodies to Infliximab on Clinical Outcomes and Serum Infliximab Levels in Patients With Inflammatory Bowel Disease (IBD): A Meta-Analysis
- (2012) Kavinderjit S Nanda et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Adalimumab elicits a restricted anti-idiotypic antibody response in autoimmune patients resulting in functional neutralisation
- (2012) Pauline A van Schouwenburg et al. ANNALS OF THE RHEUMATIC DISEASES
- Therapeutic Drug Monitoring of Tumor Necrosis Factor Antagonists in Inflammatory Bowel Disease
- (2012) Ingrid Ordás et al. Clinical Gastroenterology and Hepatology
- Addition of an Immunomodulator to Infliximab Therapy Eliminates Antidrug Antibodies in Serum and Restores Clinical Response of Patients With Inflammatory Bowel Disease
- (2012) Shomron Ben–Horin et al. Clinical Gastroenterology and Hepatology
- Anti-TNF Monoclonal Antibodies in Inflammatory Bowel Disease: Pharmacokinetics-Based Dosing Paradigms
- (2012) I Ordás et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Anti-infliximab antibodies in inflammatory bowel disease
- (2012) Lennard Y.W. Lee et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- mTNF reverse signalling induced by TNFα antagonists involves a GDF-1 dependent pathway: implications for Crohn's disease
- (2012) Stefanie Derer et al. GUT
- Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study
- (2012) Mirthe Emilie van der Valk et al. GUT
- Anti-TNF-α biotherapies: perspectives for evidence-based personalized medicine
- (2012) Klaus Bendtzen Immunotherapy
- Clinical implications of variations in anti-infliximab antibody levels in patients with inflammatory bowel disease
- (2012) Casper Steenholdt et al. INFLAMMATORY BOWEL DISEASES
- Mucosal Healing in Crohnʼs Disease
- (2012) Peter De Cruz et al. INFLAMMATORY BOWEL DISEASES
- IgG4 Production Against Adalimumab During Long Term Treatment of RA Patients
- (2012) Pauline A. van Schouwenburg et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Results of the 2nd scientific workshop of the ECCO (IV): Therapeutic strategies to enhance intestinal healing in inflammatory bowel disease
- (2012) Alessandro Armuzzi et al. Journal of Crohns & Colitis
- Infliximab trough levels may predict sustained response to infliximab in patients with Crohn's disease
- (2012) Martin Bortlik et al. Journal of Crohns & Colitis
- Development and validation of a homogeneous mobility shift assay for the measurement of infliximab and antibodies-to-infliximab levels in patient serum
- (2012) Shui-Long Wang et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Mucosal cytokine gene expression profiles as biomarkers of response to infliximab in ulcerative colitis
- (2012) Renathe Rismo et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Outcome after discontinuation of infliximab in patients with inflammatory bowel disease in clinical remission: an observational Danish single center study
- (2012) Casper Steenholdt et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Predictors of dose escalation of adalimumab in a prospective cohort of Crohn’s disease patients
- (2011) E. Bultman et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Randomised clinical trial: improvement in health outcomes with certolizumab pegol in patients with active Crohn’s disease with prior loss of response to infliximab
- (2011) B. G. Feagan et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Severe infusion reactions to infliximab: aetiology, immunogenicity and risk factors in patients with inflammatory bowel disease
- (2011) C. Steenholdt et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study
- (2011) M. Chaparro et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn’s disease
- (2011) L. S. Kiss et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Review article: remission rates achievable by current therapies for inflammatory bowel disease
- (2011) L. Peyrin-Biroulet et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease
- (2011) Nicholas J Talley et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Loss of Response and Need for Adalimumab Dose Intensification in Crohn's Disease: A Systematic Review
- (2011) Vincent Billioud et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Assessing Response and Loss of Response to Biological Therapies in IBD
- (2011) Henit Yanai et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Gene Expression Profiling and Response Signatures Associated With Differential Responses to Infliximab Treatment in Ulcerative Colitis
- (2011) Gary Toedter et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Efficacy of Biological Therapies in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
- (2011) Alexander C Ford et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis
- (2011) T. Takeuchi et al. ANNALS OF THE RHEUMATIC DISEASES
- Is there a need for immunopharmacologic guidance of anti-tumor necrosis factor therapies?
- (2011) Klaus Bendtzen ARTHRITIS AND RHEUMATISM
- Levels of C-reactive Protein Are Associated With Response to Infliximab Therapy in Patients With Crohn's Disease
- (2011) Matthias Jürgens et al. Clinical Gastroenterology and Hepatology
- Durability of Infliximab Dose Intensification in Crohn’s Disease
- (2011) Kirk K. Lin et al. DIGESTIVE DISEASES AND SCIENCES
- Epidemiology and Natural History of Inflammatory Bowel Diseases
- (2011) Jacques Cosnes et al. GASTROENTEROLOGY
- Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped
- (2011) Edouard Louis et al. GASTROENTEROLOGY
- Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease
- (2011) Laurent Peyrin-Biroulet et al. GUT
- Guidelines for the management of inflammatory bowel disease in adults
- (2011) C. Mowat et al. GUT
- Practical application of anti-TNF therapy for luminal Crohnʼs disease
- (2011) Michael A. Kamm et al. INFLAMMATORY BOWEL DISEASES
- Trough Levels and Antibodies to Infliximab May Not Predict Response to Intensification of Infliximab Therapy in Patients With Inflammatory Bowel Disease
- (2011) Benjamin Pariente et al. INFLAMMATORY BOWEL DISEASES
- Stopping immunomodulators and biologics in inflammatory bowel disease patients in remission
- (2011) Kofi Clarke et al. INFLAMMATORY BOWEL DISEASES
- Therapeutic Drug Monitoring of Biologics for Inflammatory Bowel Disease
- (2011) Jean-Frédéric Colombel et al. INFLAMMATORY BOWEL DISEASES
- Clinical utility of antihuman lambda chain-based enzyme-linked immunosorbent assay (ELISA) versus double antigen ELISA for the detection of anti-infliximab antibodies
- (2011) Uri Kopylov et al. INFLAMMATORY BOWEL DISEASES
- Development of Antidrug Antibodies Against Adalimumab and Association With Disease Activity and Treatment Failure During Long-term Follow-up
- (2011) Geertje M. Bartelds JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Profiles of circulating cytokines in patients with Crohn's disease under maintenance therapy with infliximab
- (2011) Kotaro Ogawa et al. Journal of Crohns & Colitis
- Intensification of infliximab therapy in Crohn's disease: Efficacy and safety
- (2011) M.Chaparro et al. Journal of Crohns & Colitis
- Reporter gene assay for the quantification of the activity and neutralizing antibody response to TNFα antagonists
- (2011) Christophe Lallemand et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Differential effect of drug interference in immunogenicity assays
- (2011) Margreet H. Hart et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Antibodies to constant domains of therapeutic monoclonal antibodies: Anti-hinge antibodies in immunogenicity testing
- (2011) Theo Rispens et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Surprising negative association between IgG1 allotype disparity and anti-adalimumab formation: a cohort study
- (2011) Geertje M Bartelds et al. ARTHRITIS RESEARCH & THERAPY
- Annual costs of tumor necrosis factor inhibitors using real-world data in a commercially insured population in the United States
- (2011) Vernon F. Schabert et al. JOURNAL OF MEDICAL ECONOMICS
- Genetic polymorphisms of tumour necrosis factor receptor superfamily 1A and 1B affect responses to infliximab in Japanese patients with Crohn’s disease
- (2010) H. MATSUKURA et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Maintenance of clinical benefit in Crohn’s disease patients after discontinuation of infliximab: long-term follow-up of a single centre cohort
- (2010) A. W. G. Waugh et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab
- (2010) C. Taxonera et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organization: When to Start, When to Stop, Which Drug to Choose and How to Predict Response?
- (2010) Geert R D'Haens et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Clinical Utility of Measuring Infliximab and Human Anti-Chimeric Antibody Concentrations in Patients With Inflammatory Bowel Disease
- (2010) Waqqas Afif et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Regulatory T cells control the transition from acute into chronic inflammation in glucose-6-phosphate isomerase-induced arthritis
- (2010) O. Frey et al. ANNALS OF THE RHEUMATIC DISEASES
- Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis
- (2010) R. A. Harry et al. ANNALS OF THE RHEUMATIC DISEASES
- Patients with RA in remission on TNF blockers: when and in whom can TNF blocker therapy be stopped?
- (2010) B. Saleem et al. ANNALS OF THE RHEUMATIC DISEASES
- Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies
- (2010) Diane R. Mould et al. BIODRUGS
- Dealing with immunogenicity of biologicals: assessment and clinical relevance
- (2010) Gerrit J Wolbink et al. CURRENT OPINION IN RHEUMATOLOGY
- The immunogenic part of infliximab is the F(ab')2, but measuring antibodies to the intact infliximab molecule is more clinically useful
- (2010) S. Ben-Horin et al. GUT
- Usefulness of co-treatment with immunomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapy
- (2010) H. Sokol et al. GUT
- Monitoring functional serum antitumor necrosis factor antibody level in Crohnʼs disease patients who maintained and those who lost response to anti-TNF
- (2010) Akihiro Yamada et al. INFLAMMATORY BOWEL DISEASES
- Predictive value of epithelial gene expression profiles for response to infliximab in Crohnʼs disease‡
- (2010) Ingrid Arijs et al. INFLAMMATORY BOWEL DISEASES
- Dosage adjustment during long-term adalimumab treatment for Crohnʼs disease: Clinical efficacy and pharmacoeconomics
- (2010) William J. Sandborn et al. INFLAMMATORY BOWEL DISEASES
- The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
- (2010) A. Dignass et al. Journal of Crohns & Colitis
- Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: Definitions, frequency and pharmacological aspects
- (2010) Matthieu Allez et al. Journal of Crohns & Colitis
- A novel method for the detection of antibodies to adalimumab in the presence of drug reveals “hidden” immunogenicity in rheumatoid arthritis patients
- (2010) Pauline A. van Schouwenburg et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
- (2010) Jean Frédéric Colombel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cut-off levels and diagnostic accuracy of infliximab trough levels and anti-infliximab antibodies in Crohn's disease
- (2010) Casper Steenholdt et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Systematic review: the short-term and long-term efficacy of adalimumab following discontinuation of infliximab
- (2009) C. MA et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Loss of Response and Requirement of Infliximab Dose Intensification in Crohn's Disease: A Review
- (2009) Javier P Gisbert et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Anti-adalimumab antibodies in rheumatoid arthritis patients are associated with interleukin-10 gene polymorphisms
- (2009) G. M. Bartelds et al. ARTHRITIS AND RHEUMATISM
- TNF-alpha gene expression in colorectal mucosa as a predictor of remission after induction therapy with infliximab in ulcerative colitis
- (2009) Trine Olsen et al. CYTOKINE
- Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis
- (2009) Adedigbo A. Fasanmade et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Influence of Trough Serum Levels and Immunogenicity on Long-term Outcome of Adalimumab Therapy in Crohn's Disease
- (2009) Konstantinos Karmiris et al. GASTROENTEROLOGY
- Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis
- (2009) C H Seow et al. GUT
- Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis
- (2009) I. Arijs et al. GUT
- Incidence and clinical significance of immunogenicity to infliximab in Crohnʼs disease
- (2009) Andrea Cassinotti et al. INFLAMMATORY BOWEL DISEASES
- IgG1 heavy chain-coding gene polymorphism (G1m allotypes) and development of antibodies-to-infliximab
- (2009) Charlotte Magdelaine-Beuzelin et al. Pharmacogenetics and Genomics
- Individual medicine in inflammatory bowel disease: Monitoring bioavailability, pharmacokinetics and immunogenicity of anti-tumour necrosis factor-alpha antibodies
- (2009) Klaus Bendtzen et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Review: Predicting response to anti-TNF agents for the treatment of Crohn's disease
- (2009) Corey A. Siegel et al. Therapeutic Advances in Gastroenterology
- Long-term outcome of adalimumab therapy for ulcerative colitis with intolerance or lost response to infliximab: a single-centre experience
- (2008) A. OUSSALAH et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Immunogenicity negatively influences the outcome of adalimumab treatment in Crohn’s disease
- (2008) R. L. WEST et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Autologous bone marrow transplantation in autoimmune arthritis restores immune homeostasis through CD4+CD25+Foxp3+ regulatory T cells
- (2008) S. T. A. Roord et al. BLOOD
- Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes"
- (2008) A. S. De Groot et al. BLOOD
- Efficacy and Safety of Tumor Necrosis Factor Antagonists in Crohn's Disease: Meta-Analysis of Placebo-Controlled Trials
- (2008) Laurent Peyrin–Biroulet et al. Clinical Gastroenterology and Hepatology
- Monoclonal Antibody Pharmacokinetics and Pharmacodynamics
- (2008) W Wang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Immunogenicity of anti-tumor necrosis factor antibodies—toward improved methods of anti-antibody measurement
- (2008) Lucien Aarden et al. CURRENT OPINION IN IMMUNOLOGY
- Withdrawal of Immunosuppression in Crohn's Disease Treated With Scheduled Infliximab Maintenance: A Randomized Trial
- (2008) Gert Van Assche et al. GASTROENTEROLOGY
- European evidence-based Consensus on the management of ulcerative colitis: Current management
- (2008) S.P.L. Travis et al. Journal of Crohns & Colitis
- Tumor Necrosis Factor-Alpha Binding Capacity and Anti-Infliximab Antibodies Measured by Fluid-Phase Radioimmunoassays as Predictors of Clinical Efficacy of Infliximab in Crohn's Disease
- (2007) Mark A. Ainsworth et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now